Gilead Sciences (GILD)

$110.14 1.39 (1.25%)

10:46 EST GILD Stock Quote Delayed 30 Minutes

GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?

By William White, InvestorPlace Writer May 16, 2023

Gilead Sciences (GILD) stock is a hot topic on Tuesday as a new price target predicts a roughly 28% upside for the shares.

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

Strong Quant Screens Say These 7 Growth Stocks Are a Buy

7 Cash-Rich Companies to Invest in During Economic Uncertainty

Volume:

Previous Close -

Market Cap 138.09B

PE Ratio 1,376.75

EPS 0.08

Volume (Avg. Vol.) 1.61M

Day's Range $108.40 - $110.93

52-Week Range $62.07 - $112.11

Dividend & Yield $3.08 (2.80%)

GILD Stock Predictions, Articles, and Gilead Sciences News

7 Dividend Stocks to Buy and Hold Forever

By Will Ashworth, InvestorPlace Contributor Dec 21, 2022

If you’re a dividend investor these seven dividend stocks to buy and hold forever are worth considering heading into 2023.

Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data

By Josh Enomoto, InvestorPlace Contributor Dec 20, 2022

Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock.

The 7 Best Retirement Stocks to Buy Now

By Louis Navellier and the InvestorPlace Research Staff Dec 18, 2022

Current bear market conditions present the perfect opportunity to invest in retirement stocks while they're trading at bargain valuations.

Why Is Arcellx (ACLX) Stock Up 25% Today?

By David Moadel, InvestorPlace Contributor Dec 9, 2022

ACLX stock is usually under the radar, but today it's in the spotlight as Arcellx reveals a team-up with a well-known biotech business.

7 Monthly Dividend Stocks to Buy for Safety

By Muslim Farooque, InvestorPlace Contributor Sep 29, 2022

These safe monthly dividend stocks offer investors incredible dividend yields and healthy upside potential

Why Is Gilead Sciences (GILD) Stock Up Today?

By Bret Kenwell, InvestorPlace Contributor Sep 12, 2022

Gilead Sciences has a low valuation, but no growth. Perhaps settling a patent lawsuit will help give GILD stock the boost it needs.

What Is Going on With Gilead Sciences (GILD) Stock Today?

By David Moadel, InvestorPlace Contributor Aug 16, 2022

GILD stock is the focus of not just one but two news items today, and traders are trying to decide if they're bullish or bearish.

7 Growth Stocks to Buy After a 20% Correction

By Tezcan Gecgil, InvestorPlace Contributor Aug 15, 2022

These are among the best growth stocks to buy now. ADBE, AMD, GILD, LOW, MELI, MP, and PYPL are poised to benefit from strong trends in 2022.

7 Best Pharmaceutical Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor Jul 20, 2022

These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.

7 Biotech Stocks With Key Catalysts Coming in July

By Tezcan Gecgil, InvestorPlace Contributor Jun 27, 2022

Biotech stocks have suffered significant setbacks during the first half of the year but are likely to bounce back soon

7 Oversold Stocks to Buy Right Now

By Tezcan Gecgil, InvestorPlace Contributor Jun 8, 2022

Identifying oversold stocks gives investors the opportunity to buy shares that they perhaps already liked, only at a discounted price.

7 Safe Dividend Stocks With High Yields to Buy Now

By Chris Markoch, InvestorPlace Contributor May 31, 2022

Investors are seeking dividend stocks. Here are seven safe dividend stocks that offer a high yield to maximize their total return.

7 Dividend Stocks Paying Over 5% to Buy Now

By Chris Lau, InvestorPlace Contributor Apr 26, 2022

Stock markets will return less this year as interest rates rise and cause a recession, so investors should demand higher yield.

The 7 Highest Dividend Stocks for Income Investors

By Louis Navellier and the InvestorPlace Research Staff Feb 9, 2022

These dividend stocks, including SCCO stock and CQP stock, offer high yields, a proven track record and high ratings in Dividend Grader.

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

By Samuel O'Brient, InvestorPlace Reporter Feb 4, 2022

Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit.

7 Safe Stocks for Your Retirement

By Louis Navellier and the InvestorPlace Research Staff Jan 7, 2022

In a dynamic market like the one we're in now, it's important to buy safe stocks that will build your nest egg in the years to come.

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

5 M&A Stocks to Watch as Goldman Calls for a Big Jump in Deals

By Samuel O'Brient, InvestorPlace Reporter Nov 1, 2021

Goldman Sachs predicts the Democrats' new tax plan could yield positive results for M&A-focused companies. Here are the M&A stocks to watch.

3 Value Stocks to Buy While You Still Can

By David Cohne, StockNews.com Sep 20, 2021

Value stocks have been underperforming over the past few months, but that is expected to change as the economy continues to recover.

7 Stocks to Buy for Responsibility and Sustainability

By Josh Enomoto, InvestorPlace Contributor Aug 4, 2021

With social responsibility taking a greater role in politics and Wall Street, these ESG stocks may find favor in your portfolio.

Gilead Sciences (GILD)

GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

Strong Quant Screens Say These 7 Growth Stocks Are a Buy

7 Cash-Rich Companies to Invest in During Economic Uncertainty

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gilead Sciences (GILD)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GILD Stock Predictions, Articles, and Gilead Sciences News

Subscriber Sign in